139 related articles for article (PubMed ID: 11756554)
1. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan from Laminaria cichorioides inhibits AP-1 transactivation and cell transformation in the mouse epidermal JB6 cells.
Lee NY; Ermakova SP; Choi HK; Kusaykin MI; Shevchenko NM; Zvyagintseva TN; Choi HS
Mol Carcinog; 2008 Aug; 47(8):629-37. PubMed ID: 18302141
[TBL] [Abstract][Full Text] [Related]
3. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
4. c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis.
Gebhardt C; Breitenbach U; Richter KH; Fürstenberger G; Mauch C; Angel P; Hess J
Am J Pathol; 2005 Jul; 167(1):243-53. PubMed ID: 15972968
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
Dong Z; Huang C; Brown RE; Ma WY
J Biol Chem; 1997 Apr; 272(15):9962-70. PubMed ID: 9092536
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation.
Choi HS; Choi BY; Cho YY; Mizuno H; Kang BS; Bode AM; Dong Z
Cancer Res; 2005 Jul; 65(13):5818-27. PubMed ID: 15994958
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FRA1 (
Al-Khayyat W; Pirkkanen J; Dougherty J; Laframboise T; Dickinson N; Khaper N; Lees SJ; Mendonca MS; Boreham DR; Tai TC; Thome C; Tharmalingam S
Cells; 2023 Sep; 12(19):. PubMed ID: 37830558
[TBL] [Abstract][Full Text] [Related]
8. Multiple Fra-1-bound enhancers showing different molecular and functional features can cooperate to repress gene transcription.
Bejjani F; Evanno E; Mahfoud S; Tolza C; Zibara K; Piechaczyk M; Jariel-Encontre I
Cell Biosci; 2023 Jul; 13(1):129. PubMed ID: 37464380
[TBL] [Abstract][Full Text] [Related]
9. Targeting transcription factors for therapeutic benefit in rheumatoid arthritis.
Balendran T; Lim K; Hamilton JA; Achuthan AA
Front Immunol; 2023; 14():1196931. PubMed ID: 37457726
[TBL] [Abstract][Full Text] [Related]
10. The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.
He YY; Zhou HF; Chen L; Wang YT; Xie WL; Xu ZZ; Xiong Y; Feng YQ; Liu GY; Li X; Liu J; Wu QP
Front Immunol; 2022; 13():954744. PubMed ID: 36032067
[TBL] [Abstract][Full Text] [Related]
11. Phorbol-12-myristate 13-acetate inhibits Nephronectin gene expression via Protein kinase C alpha and c-Jun/c-Fos transcription factors.
Kinoshita M; Yamada A; Sasa K; Ikezaki K; Shirota T; Kamijo R
Sci Rep; 2021 Oct; 11(1):20360. PubMed ID: 34645824
[TBL] [Abstract][Full Text] [Related]
12. Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.
Bejjani F; Tolza C; Boulanger M; Downes D; Romero R; Maqbool MA; Zine El Aabidine A; Andrau JC; Lebre S; Brehelin L; Parrinello H; Rohmer M; Kaoma T; Vallar L; Hughes JR; Zibara K; Lecellier CH; Piechaczyk M; Jariel-Encontre I
Nucleic Acids Res; 2021 Mar; 49(5):2488-2508. PubMed ID: 33533919
[TBL] [Abstract][Full Text] [Related]
13. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
14. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.
Vallejo A; Perurena N; Guruceaga E; Mazur PK; Martinez-Canarias S; Zandueta C; Valencia K; Arricibita A; Gwinn D; Sayles LC; Chuang CH; Guembe L; Bailey P; Chang DK; Biankin A; Ponz-Sarvise M; Andersen JB; Khatri P; Bozec A; Sweet-Cordero EA; Sage J; Lecanda F; Vicent S
Nat Commun; 2017 Feb; 8():14294. PubMed ID: 28220783
[TBL] [Abstract][Full Text] [Related]
15. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
16. Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival.
Iskit S; Schlicker A; Wessels L; Peeper DS
Oncotarget; 2015 Dec; 6(41):43146-61. PubMed ID: 26646695
[TBL] [Abstract][Full Text] [Related]
17. A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.
Stuart SA; Houel S; Lee T; Wang N; Old WM; Ahn NG
Mol Cell Proteomics; 2015 Jun; 14(6):1599-615. PubMed ID: 25850435
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
